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Summary 
We have compared transgenic mice that express the influenza virus PR8 hemagglutinin (PR8 
HA) as a membrane-bound neo-selfantigen (HA104 mice) with nontransgenic (non-Tg) mice 
for their ability to generate HA-specific B cell responses after primary immunization with PR8 
virus. HA-specific, IgM-secreting B cells were induced with similar frequencies in HA104 and 
non-Tg mice. In addition, a B cell clonotype (C4) that is characteristic of anti-HA immune re- 
sponses  of BALB/c  mice was  identified  among HA-specific IgM  hybridomas from HA104 
mice. A  subset of HA-specific, IgG-secreting B  cells that arises rapidly after primary virus im- 
munization in non-Tg mice, however, was substantially reduced in HA104 mice. Likewise, a 
B  cell clonotype  (C12)  that dominates HA-specific IgG hybridomas generated after primary 
immunization of non-Tg mice was present at greatly reduced frequencies among hybridomas 
from HA104 mice. Because HA-specific, IgG-secreting B cells were generated by HA104 mice 
in response to a mutant HA containing an amino acid interchange in a B cell antigenic site, we 
conclude that these PP,8 HA-specific, IgG-secreting B  cells are negatively selected in HA104 
mice as a result  of their specificity for the  neo-self PR8  HA.  The findings  demonstrate that 
HA-specific B  cells  that  display distinct  phenotypic potentials in  non-Tg mice also  differ in 
their susceptibility to negative selection from the primary B  cell repertoire of HA104 mice: a 
subset  of B  cells  that  undergo  rapid  differentiation  to  become  HA-specific  IgG antibody- 
secreting cells (ASC) after activation in non-Tg mice is negatively selected in HA104 mice. By 
contrast, a subset that gives rise to HA-specific, IgM-secreting ASC persists in the primary rep- 
ertoire of HA104 mice and can be activated by virus immunization. 
D 
uring their development, B cells undergo a program of 
gene  rearrangements  to  generate  unique  Ig variable 
(V) 1 region domains that determine their antigenic specific- 
ity (1). Signals received by these antigen receptors play a cen- 
tral role in directing the differentiation orB cells into a vari- 
ety of functionally distinct  phenotypes. Under the appropriate 
conditions,  mature  B  cells  respond  to  receptor-mediated 
signaling by undergoing proliferation and differentiation to 
produce antibody-secreting cells  (ASC) and/or memory B 
cells (2, 3). These differentiated B cell populations have dis- 
tinct functional potentials for postactivation events such as 
somatic  hypermutation  and  antibody  secretion,  and  they 
appear to develop along different pathways, as indicated by 
their discrete anatomical locations, differential expression of 
clonotypes, and other cell-surface markers (4-10). 
1Abbreviations used in this paper: ASC, antibody-secreting  cell; HA, hemag- 
glutinin; HAU, hemagglutinating units; RT, reverse transcriptase; TBS, 
Tris-buffered saline; Tg, transgenic; V, variable. 
Under  other  conditions,  both  mature  and  immature B 
cells can be inactivated or eliminated by signals  transmitted 
through their antigen receptors (11). By inducing the elim- 
ination of autoreactive B  cells, receptor-mediated signaling 
plays an important  role  in  establishing B  cell tolerance to 
self antigens. Studies using transgenic (Tg) mice expressing 
Ig specific for self antigens have identified a variety of pro- 
cesses that can lead to the inactivation or elimination of self- 
reactive B cells at different stages of their development (12). 
These different outcomes can be promoted by differences 
in the physical form of the self antigen; membrane-bound 
antigens  appear in  some model systems to promote more 
efficient deletion  of self-reactive B  cells  than  soluble ver- 
sions of the same antigen  (13,  14),  although these distinc- 
tions are not clear cut (15). Moreover, B cells that can react 
with self antigens can, in some circumstances, persist among 
peripheral B  ceils  (16,  17),  and receptor specificity for self 
antigens may participate in selection of B cells into distinct 
subsets  (18,  19).  The factors that direct B  cell differentia- 
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Volume 183 January 1996 13-26 tion into functionally distinct subsets and affect their regu- 
lation during development are not yet understood. 
We are addressing these issues by analyzing the antigen- 
specific B  cell repertoires that are induced in responses to 
the  influenza virus  PR8  hemagglutinin  (HA)  in  BALB/c 
mice, and in transgenic mice that express the PR8 HA as a 
membrane-bound neo-selfantigen (HA104 mice). The HA 
is  the  major  glycoprotein  on  the  influenza  virus  particle 
which, because of its role in mediating and evading protec- 
tive immunity to influenza virus, has been extensively char- 
acterized in terms of its immunological recognition (20). In 
the case of the PR8 HA, the locations of four major B  cell 
antigenic sites that  are recognized by BALB/c  mice  have 
been determined (21). Moreover, the genetic basis for PR8 
HA~specific  B  cell  responses  of BALB/c  mice  has  been 
studied in considerable detail (22-28). Although many dif- 
ferent VH and VL germline gene segments can be used to 
generate PR8 HA-specific anfbodies (27), these studies have 
identified B  cells that use characteristic VH and/or VK gene 
segments and are reproducibly expressed at different stages 
of anti-PR8 HA antibody responses of BALB/c mice. For 
example,  a  B  cell subset  termed  C12  that  recognizes  the 
antigenic  site  Cb  and  dominates  early primary B  cell re- 
sponses to the PR8 HA has been identified (26). Although 
they arise quickly after primary immunization, C12 B  cells 
have frequently undergone class switching and they produce 
IgG antibodies. Moreover,  C12  B  cells disappear abruptly 
during the primary response, display limited evidence of so- 
matic hypermutation, and make little or no contribution to 
secondary responses to the PR8 HA in BALB/c mice (29). 
A second B cell subset, termed C4, is likewise frequen@ rep- 
resented during primary responses (24). C4 B  cells recognize 
the antigenic site Sb; unlike C12 B  cells, however, somati- 
cally mutated C4 B  cells are represented in secondary PR8 
HA-specific B cell responses (24). By comparing HA104 mice 
with  non-Tg  mice for their HA-specific B  cell responses, 
we have found that the HA-specific, IgG-secreting B  cells 
(including C12 B  cells), which arise rapidly after virus im- 
munization  of non-Tg  mice,  are  substantially reduced  in 
HA104  mice.  By  contrast,  HA-specific,  IgM-secreting B 
cells (including C4 B  cells) are generated with similar fre- 
quencies in HA104  and non-Tg mice. The findings dem- 
onstrate that autoreactive B  cells directed to a ubiquitously 
expressed membrane-bound  self antigen can be heteroge- 
neous  with  respect  to  their  regulation;  a  subset  of HA- 
specific B  cells that undergoes rapid differentiation to pro- 
duce IgG ASC during the primary response to PR8 virus in 
non-Tg  mice  is  also  substantially eliminated from  the  pri- 
mary B  cell repertoire of HA104 mice. By contrast, a subset 
of HA-specific B  ceils that gives rise to IgM ASC persists in 
HA104 mice and can be activated by virus immunization. 
Materials and Methods 
Mice.  A  previously described DNA  construct  containing a 
cDNA copy of the PR8 HA linked to the SV40 early region pro- 
moter/enhancer and polyadenylation signals (30) was modified to 
remove a single base deletion that introduces a premature stop 
codon in the  HA-coding sequence.  The  COOH-terminal por- 
tion of the HA-coding sequences was replaced with correspond- 
ing sequences from a PR8  HA plasmid kindly provided by Dr. 
Peter Palese  (Mount Sinai School of Medicine, New York). This 
produced a plasmid encoding a full-length copy of the  HA in- 
serted between the SV40 early region enhancer and the T antigen 
coding region, in the BglII site of the expression vector pKSV10 
(Pharmacia Fine Chemicals, Piscataway, NJ).  Plasmid sequences 
were removed and purified construct DNA was injected into fer- 
tilized BALB/cxC57B1/6  zygotes. The  HA104  lineage was  de- 
veloped from one of four founder mice by successive back-cross- 
ing to BALB/c mice (Charles River Breeding Laboratories, Inc., 
Wilmington, MA, or The Jackson Laboratory, Bar Harbor, ME). 
The mice used here had been back-crossed three to five genera- 
tions to BALB/c mice. Mice were genotyped by PCR (31) of ex- 
cised tail DNA  (32) using the primers HA2 and HAamp3'  (30). 
Non-Tg mice were in most cases transgene-negative HA104 mice; 
in a few instances,  BALB/c mice that had been maintained in our 
colony were  used  as  non-Tg  mice.  Mice were  housed  in  mi- 
croisolator cages and were between 2 and 5 mo old before immu- 
nization. 
Transgene mRNA Expression.  RNA was isolated from the kid- 
ney, spleen, thymus, heart, lung, intestine, and bone marrow of a 
6-wk-old HA104 mouse by lysis of tissues in guanidinium isothio- 
cyanate followed by passage over a CsC1 gradient (33). cDNA was 
produced by reverse transcription (RT) of 20  ~,g of total RNA 
primed with the previously described primers SV40 poly(A), which 
contains oligo dT plus a four-nucleotide extension corresponding 
to the SV40 early region poly(A) site that forms the 3' end of the 
transgene mRNA, as well as the MHC class l~pecific primer H2D  a 
3' (30). The resulting cDNA was amplified in the PCR for 35 cy- 
cles under standard conditions (31) with either SV40 poly(A) and 
SV40-PCRS', or H2D  a 3' and H2D  a 5'  (30).  To identify trans- 
gene-specific amplification products, gels were Southern blotted 
and probed with a 32p-labeled oligonucleotide (SV40 probe) (30). 
lmmunohistochemistry.  A three-step immunoalkaline phosphatase 
method was used to localize expression of the HA protein in fro- 
zen sections of spleen and thymus or cytocentrifuge preparations 
of mononuclear bone marrow cells, which were obtained from a 
5-wk-old HA104 mouse. All samples were fixed in acetone be- 
fore incubation with mouse Ig (50 bLg/ml; Sigma Chemical Co., 
St. Louis, MO) in Tris-buffered saline (TBS, 10 mM Tris, 0.15 M 
NaC1,  pH 7.3)  to prevent nonspecific binding of primary anti- 
bodies.  Duplicate samples were  incubated for  30  min  at  20~ 
with either the rat anti-PR8 HA IgG mAb 10-1  or a control rat 
IgG antibody of irrelevant specificity diluted in TBS +  1% BSA. 
Slides were washed in TBS, incubated with a secondary biotiny- 
lated mouse anti-rat antibody (mouse adsorbed; Vector Laborato- 
ries, Burlingame, CA) for 30 min at 20~  washed, and incubated 
with an alkaline phosphatase-conjugated avidin-biotin complex 
(Vector Laboratories). After washing, the samples were incubated 
with a tertiary alkaline phosphatase-conjugated rat anti-alkaline 
phosphatase  antibody  (Harlan  Bioproducts,  Indianapolis,  IN), 
washed again, and then enzyme activity was developed using the 
Vector Red substrate (Vector Labortories). Samples were washed, 
air dried, and mounted for photomicroscopy. 
Viruses and Immunizations.  Influenza viruses PR8  [A/Puerto 
Rico/8/34  (H1NI)], T3  (a mutant PRB virus containing an as- 
partic acid to glycine interchange at amino acid 225)  (21),  and 
J1  [a  H3N1  reassortant  between  PR8  (H1N1)  and  A/Hong 
Kong/1/68 (H3N2), in which the PR8 HA has been replaced by 
the serologically  non-cross-reactive H3 subtype HA[ (34, 35) were 
grown in the allantoic cavity of 10-d-old embryonated hen's eggs 
14  Activation and Negative Selection of Hemagglutinin-specific B cells and purified by sucrose gradient centrifugation. Virus titers were 
determined  by  agglutination of chicken  erythrocytes  and  ex- 
pressed as hemagglutinating units (HAU) as described (36).  Mice 
were immunized by injecting 1,000 HAU of purified vires intra- 
venously in 0.2 ml PBS. 
ELISPOTAnalysis.  Purified P1L8, T3, and J1  viruses (1,000 
HAU/ml in PBS)  were  applied in 0.1-ml vol to  nitrocellulose- 
based 0.45-txM filters in 96-well microtiter plates  (Multiscreen- 
HA; Millipore Corp., Bedford, MA). After overnight adsorption 
at 4~  plates were washed and blocked by incubation at 37~  for 
at least 1 h with IMDM (GIBCO BRL, Gaithersburg, MD) sup- 
plemented with 50 IxM 2-ME, 5 ~g/ml iron-saturated transferrin 
(Sigma),  50 Ixg/ml gentamycin (ISC), plus 5% FBS (Hyclone Lab- 
oratories, Logan, UT) (ISC +  5%).  Splenocytes from immunized 
mice were erythrocyte depleted and washed three times in ISC + 
5%. Cells were added in quadruplicate in 0.2 ml vol at 106, 2.5 ￿ 
105, 6.3  ￿  104, and 1.6  ￿  104 cells/ml in ISC  +  5% to virus- 
coated wells, and were incubated for 4 h at 37~  in a humidified 
incubator containing 7% CO2. Filters were then washed, blocked 
for 30  min with PBS  +  1% BSA,  and incubated with alkaline 
phosphatase-conjugated goat antisera specific for mouse IgM or 
IgG H  chains (Fisher Scientific Co., Pittsburgh, PA)  (100 txl vol 
ofa 1 : 1,000 dilution in PBS +  1% BSA) overnight at 4~  Wells 
were washed and developed with 0.33 mg/ml nitro blue tetrazo- 
lium and 0.17 mg/ml 5-bromo-4-chloro-3-indolyl phosphate in 
0.1 M NaHCO3 and 0.001 M MgC12, pH 9.8. Spots were counted 
with the aid of a dissecting microscope, and mean counts derived 
from cell dilutions that yielded discrete  spots were  expressed as 
numbers of ASC per 10  s splenocytes. In control experiments, sple- 
nocytes from unimmunized mice were  generally found to yield 
spots at cell concentrations >106/ml; no difference was apparent 
in unimmunized HA104 and non-Tg mice. Accordingly, the lower 
detection limit for this assay is roughly one ASC per 105 spleno- 
cytes. 
Hybridoma Generation.  Hybridomas were generated from T3- 
immunized mice 5 d  after immunization by fusion with Sp2/0- 
Ag14 (37) as previously described (28), except that hypoxanthine- 
azaserine (Sigma)  was used to select for hybridomas. After fusion, 
cells were plated at limiting dilution and generally gave rise to <30 
hybridomas per 96-well plate. HA-specific antibodies were initially 
selected by screening fivefold diluted culture supernatants for re- 
activity with T3 but not  J1 viruses; those displaying more than three- 
fold higher reactivity with T3 than J1  were  expanded, and their 
culture supernatants were analyzed in serial dilution for reactivity 
with T3, PR8, and J1 viruses, and for antibody isotype. R.oughly 
70% of the hybridomas that were initially selected from either non- 
Tg or HA104 mice yielded stable hybridoma cell lines secreting HA- 
specific antibodies. The hybridomas were generated and screened 
in three experiments, each containing one transgene-positive and 
one transgene-negative mouse. In the hybridoma designation, the 
prefix indicates the individual donor mouse, and the suffix indi- 
cates  the  individual hybridoma  number.  Mice  920  (Tg§  921 
(Tg§  and 922  (Tg-) were littermates, as were  1343  (Tg  §  and 
1344 (Tg-). Mouse 963 was a Tg- mouse. 
Virus-Binding ELISA.  Purified  T3,  PR8,  or J1  viruses  (20 
HAU in 25 txl PBS) were adsorbed to the wells of polyvinyl 96- 
well plates by incubation at 4~  overnight, after which they were 
washed and blocked by incubation with PBS +  1% BSA. Hybri- 
doma culture supernatants or serum antibody samples were  di- 
luted in PBS +  1% BSA, added in duplicate (25 Ixl/well), and in- 
cubated at room temperature for 2 h. The wells were then washed 
and incubated with either a biotinylated goat anti-mouse total Ig 
polyclonal antiserum (diluted 1 : 1,000; Fisher), which was used in 
preliminary screening of hybridomas, or biotinylated isotype-spe- 
cific antisera (diluted 1 : 1,000; Sigma), which were used to deter- 
mine antibody isotype. After incubation for 2 h at room tempera- 
ture,  wells were  washed and incubated with extravidin-alkaline 
phosphatase (diluted 1 : 2,000; Sigma) and incubated for 30 min at 
room temperature. Plates were again washed and incubated with 
p-nitrophenyl phosphate  (1 mg/ml in 0.1 M  NaHCO3, 0.001 M 
MgC12, pH 9.8)  for 30 min after which the reaction was termi- 
nated by addition of 0.3 M  NaOH.  Absorbance at 405 nm was 
determined using a microplate reader. 
Sequence Analysis of Antibody Variable Regions.  Roughly 106 hy- 
bridoma cells were washed with 1 ml of NTE  (0.1  M  NaC1,  10 
mM Tris-HC1, pH 7.5,  1 mM EDTA) at 4~  and then lysed for 
5 rain on ice in 200 Ixl of cold NTE +  0.5% NP-40. Nuclei were 
pelleted, and supernatants were added to 200 Ixl of 0.3 M  NaC1, 
0.2 M  Tris-HC1, pH 8.0, 25 mM EDTA, 2% SDS,  400 Ixg/ml 
proteinase K, and were incubated at 37~  for 1 h. ILNA samples 
were extracted with phenol/chloroform, ethanol precipitated, and 
redissolved in 10 mM Tris-HC1, pH 8.0, 0.1 mM EDTA. The L 
chain constant region-specific primer CK  (5'-dAGATGGATA- 
CAGTTGGT-Y) and the appropriate H  chain constant region- 
specific primer [C'y cross  (5'-dGGGGCCAGTGGATAGAC-3'), 
specific for IgGga and IgGgb constant regions; Cy3 (5'-dATGGG- 
GCTGTTGTTTGTA-3'), specific for IgG3 constant regions; Ctx 
(5'-dAGACATTTGGGAAGGAC-3'), specific for IgM constant 
regions] were used to prime cDNA synthesis from aliquots (~1/ 
10 of the total RNA sample) using RT in 100 I~1 vol under stan- 
dard  conditions (33).  After incubation, reaction mixtures  were 
boiled and aliquots (2 Ixl) were subjected to 35 cycles of amplifi- 
cation in the PCR in 50 t~1 vol under standard conditions (31) 
using the  appropriate  constant region-specific primers  and  the 
following V region primers. For H  chains, separate reactions con- 
mining either VH5'I  (5'-dGAGGTGAAGCTGGTGGAG(A/T)- 
C(A/T)GG-3') or VH5'2 (5'-dCAGGTCCAGTTGCAGCAG- 
(A/T)C(A/T)GG-3') were  carried  out  (27).  For L  chains,  one 
reaction was carried out with the degenerate VK-specific primer 
L5  (38)  that can amplify VL regions derived from a wide variety 
ofVK gene groups, but does not amplify an out-of-frame mRNA 
that is present in hybridomas generated using the Sp2/0-Ag14 fu- 
sion partner (27, 39). A second PCtl, reaction was carried out using 
a mixture of the primers VKC12  (5'-dGTCATATTGTCCAG- 
TGGA-Y) and VKC4 (5'-dCAGTCTCCATCCTCCCTGAC-3'), 
which can hybridize to the VKC12 and VKC4 gene segments. Am- 
plified reaction products were fractionated by electrophoresis on a 
1.5%  agarose  gel and purified using GeneClean II  (Biol01,  La 
Jolla,  CA).  PCR  reaction products  were  directly sequenced as 
double-stranded DNA using Sequenase (U.S. Biochemical Corp., 
Cleveland, OH) under standard conditions using the appropriate 
constant region--specific primer. For the hybridomas 922-22, 922- 
23, and 922-42, additional short-range sequencing reactions were 
carried out using 32p-end-labeled constant region primers to con- 
firm the presence of IgGga-, IgGgb-, and IgG3-specific nucleotide 
substitutions. The L chain sequence ofhybridoma 922-177 (which 
contains a putative somatic mutation) was established by sequenc- 
ing PC1L products generated from two independent cDNA reac- 
tions. 
Results 
To generate transgenic mice that express the PR8 HA gly- 
coprotein as a neo-selfantigen, a full-length, double-stranded 
DNA  copy of the PR8 virus HA gene segment was linked 
15  Caton et al. to sequences containing the SV40 early region promoter/en- 
hancer and polyadenylation signals. Transgenic  mice were 
generated by injecting the  HA/SV40 DNA  construct into 
fertilized BALB/cxC57BL/6  zygotes,  followed  by  subse- 
quent  back-crossing to BALB/c  mice.  Offspring from the 
HA104 lineage were found by Northern hybridization anal- 
ysis to express low levels of transgene mRNA  in several tis- 
sues, including the intestine, thymus,  and spleen (data not 
shown).  A  more  sensitive analysis of the  tissues in  which 
the transgene mRNA  is expressed was obtained using RT- 
PCR  to amplify transgene mRNA  sequences from various 
tissues (Fig. 1). Because the HA/SV40 construct uses SV40- 
derived splicing signals (which do not contain conventional 
introns),  it was  not  possible to  use  intron-spanning PCR 
primers to ensure that transgene-specific PCR reaction prod- 
ucts were derived from mRNA  and not from contaminating 
DNA that might be present in the mRNA  preparations. Ac- 
cordingly, one  of the primers used in  the  RT-PCR  reac- 
Figure  1.  HA mRNA is expressed in many tissues in HA104 Mice. 
Total RNA was isolated from multiple organs (K, kidney; S, spleen; T, 
thymus; H, heart; L, lung; I, intestine; and B, bone marrow) ofa 6-wk- 
old HA104 mouse, and used as a template for reverse transcription primed 
by a poly-T oIigonucleotide anchored by four bases of homology to the 
known SV-40 polyadenylation signal, which forms the 3' end of the HA 
transgene mRNA (40). The resulting cDNA was amplified  by PCR using 
the same anchored primer and a transgene-specific  5' primer. PCR prod- 
ucts were separated on a 1.2% agarose gel and stained with ethidium bro- 
mide (top  panel). This primer pair yields a 294-bp fragment upon amplifi- 
cation of transgene mRNA, which is not apparent by ethidium bromide 
staining, but is detected by hybridization with a transgene-specific  probe 
(middle panel). To establish that the anchored primer pair only amplifies 
mRNA and not DNA, 1 p.g ofgenomic DNA from the same mouse was 
used in a parallel PCR reaction (lane D). Although PCR products were 
generated from genomic DNA, transgene-specific  hybridization was not 
observed (middle  panel, lane D). The presence of the transgene in the ge- 
nomic DNA was confirmed by amplification  using the set of HA-specific 
primers used to genotype the HA Tg mice, which yield a 740-bp frag- 
ment (toppanel, lane C). The integrity of  the RNA and DNA samples  was 
confirmed by reverse transcriptase  PCR using MHC class I-specific prim- 
ers. The amplified products were fractionated on a 1.2% agarose gel and 
stained with ethidium bromide (bottom  panel). The MHC class I-specific 
primers span an intron,  resulting in a large product from DNA (bottom 
panel, lane D) than from RNA (bottom  panel, lanes K-B). 
tions [comprised ofoligo(dT) plus a four-nucleotide exten- 
sion  corresponding  to  the  SV40  early region  poly(A)  site 
(40)] was designed to hybridize to the poly(A) tail present at 
the 3' end of the transgene mRNA. The low sequence com- 
plexity of this primer allows it to hybridize to other cellular 
mRNAs, yielding multiple PCR  reaction products. Among 
these reaction products, transgene mRNA-specific sequences 
were detected by Southern hybridization analysis in all tis- 
sues that were  examined  (Fig.  1).  Importantly, this primer 
was unable to direct amplification of transgene-specific se- 
quences from genomic DNA  (Fig. 1, lane D). We also per- 
formed inmmnohistochemical analysis of tissue sections from 
the spleen and thymus, as well as ofcytocentrifuge prepara- 
tions of mononuclear bone marrow cells, and we observed 
staining of individual cells using a PR8 HA-specific mono- 
clonal antibody (Fig. 2). Together, these data indicate that the 
HA is an immunoreactive membrane-bound neo-selfantigen 
that is expressed at low levels in many tissues in HA104 mice. 
Induction of  PR8 HA-specfc Antibody Secreting Cells in HA 104 
and Non-Tg Mice.  To examine how the neo-selfPR8 HA 
affects the  peripheral B  cell repertoire, HA104  mice were 
compared with  non-Tg  mice  for  their ability to  generate 
HA-specific B  cell responses. Since the HA is expressed in 
the thymus of HA104 mice, the induction of CD4 + T  cell 
tolerance to the HA could limit their ability to generate HA- 
specific, T-dependent B  cell responses (16, 41, 42). We there- 
fore immunized HA104  and non-Tg mice with  intact in- 
fluenza virus so that T  cells directed to other proteins in the 
virus particle could provide a source ofintermolecular cog- 
nate help to HA-specific B  cells (43). A  similar approach has 
been applied in other transgenic systems to analyze B  cell re- 
sponses to neo-selfantigens under conditions in which T  cell 
tolerance was also established to the neo-selfantigen (16, 41, 
42).  HA104  and  non-Tg  mice  were  immunized  intrave- 
nously with  purified PR8  virus;  5  d  later,  the  mice were 
killed and the frequency of HA-specific ASC in the spleen 
was  determined by ELISPOT  assays (44).  Previous studies 
have demonstrated a peak of HA-specific ASC formation in 
splenocytes 5  d  after intravenous immunization with influ- 
enza virus (45). To determine the frequency of HA-specific 
ASC, the number of ASC that reacted with PR8 virus was 
compared to the number  that reacted with the control vi- 
res J1. j1  is a  reassortant virus that contains a  serologically 
non-cross-reactive H3  subtype  HA,  but  that  is otherwise 
identical to PR8  (34, 35). The frequency ofJl-specific ASC 
quantitates the ASC that are directed to non-HA viral com- 
ponents  (i.e., other virus proteins and components  such  as 
carbohydrates that derive from propagating the virus in hen's 
eggs); the frequency of PR8  HA-specific ASC is therefore 
indicated by the excess frequency of PR8-specific ASC over 
Jl-specific ASC. 
In non-Tg mice, the mean frequency ofPR8 HA~pecific 
ASC was  58.2  -+  22.5  per  105  splenocytes and  comprised 
both IgM and IgG ASC (mean frequencies  =  34.2  +  16.0 
and  24.0  +  17.2  ASC  per  10  s  splenocytes,  respectively) 
(Fig. 3). These values are in good agreement with previous 
estimates of the  frequencies  of HA-specific IgM  and  IgG 
ASC in splenocytes 5 d after intravenous immunization with 
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Figure  2.  Immunohistochemical analysis of HA protein expression in 
HA104 mice. Cytocentrifuge preparations of bone marrow mononuclear 
cells (A and B), spleen sections (C and D), and thymic sections (E and F) 
from a HA104 mouse were incubated with a control rat IgG antibody (A, 
C, and E), or with a rat anti-PR8  HA IgG antibody (B, D, and F), fol- 
lowed  by  a  three-step  immunoalkahne phosphatase staining  to  detect 
bound rat IgG.  Arrows indicate some of the individual cells  that display 
PR8 HA-specific staining in B, D, and F.  ￿ 
influenza virus  (45).  In HA104 mice,  the  mean frequency 
of PR8 HA-specific ASC was half of that observed in non- 
Tg mice (27.7  +  10.2 ASC per 105 splenocytes).  This de- 
crease was caused by a substantial reduction in the frequency 
of PR8  HA-specific  IgG ASC: although  the frequency of 
IgM  ASC  was  reduced  slightly  relative  to  non-Tg  mice 
(23.4  +  8.9 in HA104 mice versus 34.2  +  16.0 in non-Tg 
mice),  the  frequency of IgG ASC was more  than  fivefold 
lower  in  HA104  mice  than  in  non-Tg  mice  (4.3  2  4.5 
ASC  per  105  splenocytes  in  HA104  mice  versus  24.0  2 
17.2 in non-Tg mice). 
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Figure 3.  HA-specific ASC formation in PR8-immunized non-Tg and 
HA104 mice. Six non-Tg (A) and six HA104 (B) mice were each immu- 
nized with  1,000  HAU PR8  virus intravenously, and 5  d  later the fre- 
quencies ofPR8  (P)- and J1  (])-specific ASC in splenocytes were deter- 
mined by ELISPOT.  Closed symbols, the frequencies of IgM ASC; open 
symbols, the frequencies of IgG ASC  from individual mice; columns, the 
mean frequencies in each set. 
HA-specific Antibody  Responses of HAl04 Mice to Mutant 
Virus T3.  To examine the basis for the reduced frequency 
of PR8  HA-specific  IgG ASC  in  HA104  mice,  we  ana- 
lyzed the specificity and kinetics of their B  cell responses to 
a mutant virus (T3) that differs from the PR8 HA by a sin- 
gle aspartic  acid to glycine interchange  in  one of the four 
major  B  cell  antigenic  sites  (antigenic  site  Ca)  (21).  We 
have previously shown that the majority of HA-specific an- 
tibodies from BALB/c mice react equally well with the T3 
and PR8 HA molecules; a fraction (,--45%) ofT3 HA-spe- 
cific antibodies  from BALB/c mice react with  T3  but  do 
not cross-react with  PR8 because  they recognize epitopes 
that  include  the  mutated  glycine at  residue  225  (28).  We 
therefore  examined  whether  negative  selection  of PR8 
HA-specific B  cells  skewed the specificity of the B  cell re- sponse  to  the  mutant virus  T3  away from reactivity with 
the neo-selfPR8 HA in HA104 mice, as occurs in xeno- or 
alloantibody responses to variants of self proteins (46-48). 
Accordingly, HA104 and non-Tg mice were immunized 
intravenously  with  purified  T3  virus;  at  various  intervals, 
individual mice were killed,  and the frequency of HA-spe- 
cific ASC in splenocytes was determined. To determine the 
frequencies ofT3 and PR8 HA-specific ASC, the frequen- 
cies of ASC that reacted in ELISPOT with T3 virus, PR8 
virus, and the control virus J1 were determined.  In non-Tg 
mice,  HA-specific ASC were  induced  by day  3  after  T3 
immunization and were exclusively IgM (Fig.  4).  The fre- 
quency of HA-specific ASC reached a peak on day 5  and 
comprised IgM and IgG ASC in roughly equal proportions. 
HA-specific ASC declined in frequency through day 7, and 
by day 9, they were o,15% of their frequency on day 5.  In 
some instances, a small excess ofT3 over PR8 HA~pecific 
ASC was evident  (particularly on the fifth day after injec- 
tion), corresponding to ASC that were directed to the mu- 
tated glycine at residue 225. Overall, however, the frequen- 
cies of T3- and PR8 HA-specific ASC in T3-immunized, 
non-Tg mice were similar,  consistent with our previous stud- 
ies indicating that the majority of T3-specific antibodies in 
BALB/c mice are directed to shared epitopes on the T3 and 
PR8 HA molecules (28). 
In HA104  mice,  T3-  and  PR8  HA-specific  IgM ASC 
were present 3  d  after immunization at similar frequencies 
to non-Tg mice (Fig. 4).  On day 5, the mean frequencies of 
T3 and PR8 HA-specific IgM ASC were similar to non-Tg 
mice. The frequency ofPR8 HA~specific IgG ASC 5 d after 
immunization in HA104 mice,  however, was substantially 
reduced compared to non-Tg mice. Nonetheless,  T3 HA- 
specific IgG ASC were present  on day 5  in HA104 mice. 
On days 7 and 9, the frequencies ofT3- and PR8 HA-spe- 
cific IgM and IgG ASC were similar to those ofnon-Tg mice. 
ELISPOT analysis  therefore indicated that HA-specific IgM 
ASC were generated with similar kinetics  and frequencies 
in  HA104  and  non-Tg mice.  By contrast,  the  PR8  HA- 
specific IgG ASC that arise 5 d after immunization in non- 
Tg mice were substantially reduced in HA104 mice. More- 
over,  the  mean frequency of day 5  IgG ASC that reacted 
with T3 only (indicated by the excess frequency ofT3- over 
PR8-specific lgG ASC) was similar in HA Tg mice and non- 
Tg mice. Thus, the reduction ofPR8 HA~specific IgG ASC 
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Figure 4.  Kinetics  and specificity of  HA-specific  ASC formation in T3-immunized non-Tg and HA104 mice. Non-Tg (A) and HA104 (B) imce were 
immunized with 1,000 HAU T3 virus; at various time points, animals were killed and splenocytes were analyzed for the frequencies of PR8 (P)-, T3 
(T)-, and J1 (J)-specific  ASC by ELISPOT. Closed symbols indicate the frequencies oflgM ASC, and open symbols indicate the frequencies oflgG ASC. 
Three pairs ofnon-Tg and HA104 mice were analyzed  on days 3, 7, and 9, and six pairs of  mice were analyzed  on day 5. At each time point, shared sym- 
bols indicate the frequencies of  ASC derived from individual mice, and columns indicate the mean frequencies in each set. 
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PR8 HA. 
Reduced Titers of Anti-Viral IgG Serum Antibody  in HA 104 
Mice.  To examine how the frequencies of  HA-specific ASC 
affect virus-specific antibody titers in HA104  and non-Tg 
mice,  sera  from  the  T3-immunized  mice  analyzed  by 
ELISPOT were compared for their levels of PR8 virus-spe- 
cific serum antibody by ELISA (Fig.  5).  PR8 virus-specific 
IgM antibody was  induced  to  equivalent  levels  and  with 
similar  kinetics  in  non-Tg  and  HA104  mice,  reaching  a 
maximum 5 d after immunization. PR8 virus-s-specific IgG 
titers  reached  maximum levels 7  d  after immunization  in 
non-Tg  mice.  The  titers  of PR8  virus-specific  IgG  in 
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Figure  5.  Kinetics  of PR8  vims~pecific serum antibody responses in 
T3-immunized non-Tg and  HA104  mice.  Serum from the  T3-immu- 
nized non-Tg (closed symbols) and HA104 (open symbols') mice described  in 
Fig. 4 were analyzed  for their level ofPR8 virus~specific  serum antibody 
by ELISA. Data are expressed as the reciprocal of the dilution necessary to 
yield  an A405 of 0.4.  Small symbols indicate  data  points from individual 
mice; large symbols indicate  mean values  at each time point, and they are 
linked by lines. 
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HA104  mice  were  ~10%  of the  titers  in  non-Tg  mice, 
correlating with  the  reduced  frequency of PR8  HA-spe- 
cific IgG ASC that were detected by ELISPOT analysis. 
Specificity Analysis  of T3-Specific Hybridomas from HA 104 
Mice.  To analyze the HA-specific B cell responses of HA104 
mice in  greater detail,  B  cell hybridomas were  generated 
from the  splenocytes of T3-immunized HA104  and non- 
Tg mice at the peak of HA-specific ASC formation (5 d af- 
ter immunization).  Hybridoma supernatants were initially 
screened for their reactivity with T3 or J1 viruses. T3 HA- 
specific  hybridomas  were  isolated,  and  their  supernatants 
were screened in serial dilution for their reactivity with T3 
and  PR8  viruses.  Hybridomas were  designated  as  being 
T3-specific  if they  displayed 
with T3 than with PR8  (28). 
detectable reactivity with PR8 
bridomas that were designated 
mas that displayed equivalent 
>10-fold  higher  reactivity 
In most cases,  however, no 
was observed among the hy- 
as T3 HA-specific. Hybrido- 
reactivity with T3 and PR8 
were designated as being PR8 HA-specific since they were 
directed  to  epitopes that  are  shared  between  the  T3  and 
PR8  HA molecules.  The numbers of T3- and PR8  HA- 
specific  hybridomas  that  were  obtained  from  individual 
HA104 and non-Tg mice is shown in Table 1, along with 
their antibody heavy chain isotype  (all of the hybridomas 
from HA104 and non-Tg mice used K isotype L chains). The 
overall  numbers  and  H  chain  isotype  of T3  HA-specific 
hybridomas from HA104  and non-Tg mice were similar. 
The number of PR8 HA-specific hybridomas isolated from 
HA104  mice  (28  hybridomas),  however,  was reduced  by 
nearly half relative to non-Tg mice (55 hybridomas). As a re- 
sult,  the relative frequency ofT3-specific hybridomas dou- 
bled from 15% (10/65)  in non-Tg mice to 33% (14/43)  in 
HA104 mice. Among IgG hybridomas, the difference in rel- 
ative frequency of T3-specific hybridomas was even greater: 
4/43  (9%)  of the  T3  HA-specific  IgG hybridomas  from 
non-Tg mice reacted with T3, but did not cross-react with 
the PR8 HA. By contrast, 5/10 (50%) of the T3 HA-specific 
IgG hybridomas from HA104  mice  could not  cross-react 
with the PR8 HA. Specificity analysis  of hybridomas from 
T3-immunized mice therefore paralleled the results obtained 
by ELISPOT analysis:  T3 HA-specific IgM and IgG hybri- 
domas,  and  PR8  HA-specific IgM hybridomas were  iso- 
lated with similar frequencies from HA104 and non-Tg mice. 
PR8 HA-specific, IgG-secreting hybridomas, however, were 
isolated at greatly reduced frequencies from HA104 versus 
non-Tg mice. 
Differential Expression of PR8 HA-specific B Cell Clonotypes 
among Hybridomas  from HAl04 and Non- Tg Mice.  We  next 
examined the hybridomas from HA Tg and non-Tg mice 
for their usage of antibody V  region sequences that define 
B  cell clonotypes that are reproducibly expressed at differ- 
ent stages of the immune response to the PR8 HA in BALB/c 
mice. We focused on two major clonotypes: the first (desig- 
nated C12)  uses a characteristic VK gene segment (VKC12) 
from the VK4/5 group in combination with one of  two closely 
related VHJ558  gene segments (VHC12.1  and VHC12.2) 
(26). The second clonotype (designated C4) uses a character- 
istic VK gene segment (VKC4) from the VK8 group in asso- Table 1.  Specificity and H  Chain Isotype of T3 HA-specific 
Hybridomas from Non- Tg and HA 104 Mice 
Non-Tg 
T3 only~  T3 and PR81[ 
Donor  Number of 
mouse*  hybridomasr  M  G2a  G2b  G3  M  G2a  G2b  G3 
922  244  1  3  0  0  2  9  3  1 
963  248  0  1  0  0  5  10  0  0 
1344  353  5  0  0  0  9  14  1  1 
Total  845  6  4  0  0  16  33  4  2 
HA104 
T3 only~  T3 and PR_811 
Donor  Number of 
mouse*  hybridomasr  M  G2a  G2b  G3  M  G2a  G2b  G3 
921  217  4  0  0  0  11  1  0  0 
920  330  4  4  0  0  6  2  0  1 
1343  329  1  1  0  0  6  0  1  0 
Total  876  9  5  0  0  23  3  1  1 
Hybridomas generated 5 d after immunization with T3 virus were ana- 
lyzed for their reactivity with T3 and PR8 viruses and for their H chain 
isotype. 
*Donor mouse number. 
CNumber ofhybridomas screened from each mouse. 
~Number and H chain isotype of hybridomas that react with T3 only 
(>10-fold higher binding to T3  virus than to Pl<8 virus; binding to 
PR8 in most cases was undetectable). 
IINumber and H chain isotype of hybridomas that react with both T3 
and PR.8. 
ciation with the JK5 gene segment, and can combine with 
VH  gene segments derived from several gene families (in- 
cluding VHS107, VHQ52, VH7183,  and VH36-30)  to gen- 
erate specificity for the  PP-.8  HA  (24).  Mthough  the  C12 
and  C4  clonotypes were  defined in immune  responses of 
BALB/c  mice  to  PR.8  virus,  they are also induced in  re- 
sponse to the mutant T3; this is expected since the T3 mu- 
tation is located in an antigenic site (Ca) that does not form 
part of the epitopes that are recognized by C4 and C12 an- 
tibodies (which recognize epitopes in the Sb and Cb antigenic 
sites, respectively)  (21).  In addition,  although  the  HA104 
mice used here are not fully back-crossed to BALB/c mice 
and  will  contain  genes  derived  from  the  C57BL/6  back- 
ground, we have found that the C12 and C4 clonotypes are 
present  among  day  5  hybridomas  from  T3-immunized 
BALB/c ￿  C57B1/6  F1 mice (data not shown). 
The  representation  of the  C12  and  C4  clonotypes was 
examined among the PR8 HA~specific hybridomas that were 
isolated from HA104 mice. We also analyzed the PR8 HA- 
specific hybridomas from one  of the non-Tg mice  (mouse 
922)  to  establish the frequencies with which  the C12  and 
C4 clonotypes are expressed among hybridomas generated 
from a non-Tg mouse under the experimental conditions we 
adopted here. To examine C12 and C4 donotype expression, 
hybridoma mRNA  samples were amplified in the PCR with 
primers that are specific for the VKC12 and the VKC4 gene 
segments, and with degenerate VK- and VH-specific prim- 
ers, and the sequences of PCP,. products were determined. In 
some cases, hybridoma sequences could not be determined 
because the amplification products yielded mixed sequences, 
presumably because of amplification of V  region sequences 
derived from productive and nonproductive rearrangements. 
Nonetheless, hybridomas whose sequences were not deter- 
mined could usually be assigned as not using the VKC4 or 
VKC12  gene segments  (designated "not C4,  C12")  if they 
yielded mixed PCR  reaction products with the degenerate 
VK primer, but did not amplify with the C12 or C4 prim- 
ers.  The  deduced amino  acid sequences  of the hybridoma 
VH and VK regions are shown in Figs. 6 and 7. V  gene se- 
quences  that are designated as using the VKC12,  VHC12, 
and VKC4 gene segments are shown relative to these previ- 
ously described gene segments, the remaining VH  and VK 
sequences are assembled according to VH fanfily or VK group 
(51-53).  In most cases, the VH and VK sequences from in- 
dividual hybridomas were either identical (reflecting the use 
of the same germline gene segment) or they displayed mul- 
tiple substitutions that suggest the use of different germline 
gene  segments  (27).  One likely somatic mutation was  ap- 
parent  in  hybridoma  922-163,  which  contains a  substitu- 
tion  relative to  VKC12  in  L  chain  CDI<  1.  The  VK  se- 
quences of 921-25, and of 920-289 and 921-1415 also display 
a few differences relative to other hybridomas that could be 
caused by somatic mutation or by the use of closely related 
germline gene segments.  Overall, however,  somatic muta- 
tion appears to be limited among these hybridomas, consis- 
tent with other studies indicating that somatic mutation is 
rare among B  cells 5 d after immunization (54). Several sets 
ofhybridomas were also found to contain identical VH/D/ 
JH and VK/JK rearrangements, including identical H  chain 
CDR3  sequences. These sets ofhybridomas are most likely 
to have been  derived from the clonal progeny of single B 
cells (55).  In some instances, the clonal progeny expressed 
different H  chain constant region isotypes, confirming that 
they had  been  derived independently of each  other.  The 
VH and VK gene segment usage of the hybridoma panels is 
summarized in Table 2. 
Among the 17 hybridomas from non-Tg mouse 922, five 
hybridomas  (all  IgG  isotype)  used  the  VHC12.1/VKC12 
combination  of the  C12  clonotype,  and  two  hybridomas 
(both  IbM isotype) used  the VKC4/JK5  combination  that 
characterizes the  C4  clonotype.  The  C12  hybridomas in- 
cluded one pair of clonally-related hybridomas, two  addi- 
tional hybridomas  that  express  the  VKC12  L  chain  were 
not included in this set because they used VH regions that 
are  not  known  to  be  associated with  C12  antibodies.  In 
contrast to non-Tg mouse 922, the C12 clonotype was rare 
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NY~N.  ~K~A  EIRLKSNNYATHYAESV~  ~FT~SRDOSKSSVYLC~4NNLRAEDTGIYYC~  ~D~Q)YYANOY.,  ~'TSV~  3H4 
SGYYWN  ~I~N~  YISYOGSNNYNPSLKN..,  ~ISI~K~FXLKLNSV~TEDTAWYCA!  PYYGSSYGFAY..  ~GTLV  3H3 
Figure 6.  Deduced amino acid sequences 
of VH  regions of PR8  HA-specific hybri- 
domas from non-Tg and HA104 mice. Hy- 
bridomas with the prefix 922 were derived 
from the non-Tg mouse 922; those bearing 
the prefixes 920, 921, or 1343 were derived 
from HA104  mice 920,  921,  or  1343,  re- 
spectively. Sequences have been assembled 
according to the VH gene family (which is 
indicated),  and they are displayed in  refer- 
ence to a member of each group; hybrido- 
,as  that use the VHC12.1  gene are shown 
relative to the previously described VHC12.1 
sequence (26).  Identity with the representa- 
tive sequence is indicated by dashes, differ- 
ences are indicated by the single-letter alrdno 
acid code, and ambiguities are indicated by 
X.  The sequences are numbered according 
to Kabat et al.  (49),  and the locations of the 
CDP,  s  are  indicated.  Gaps that  have been 
introduced to  maintain alignment are indi- 
cated by dots. The JH gene segment that is 
used is also indicated; JHlb  refers to an al- 
lele  of the JH1  gene  segment that  derives 
from  the  C57B1/6  background  (50).  The 
nucleotide sequences of these V regions are 
available from EMBL/Genbank/DDJB  un- 
der accession numbers U37842-U37877. 
among  hybridomas  from  HA104  mice.  No  C12  hybrido- 
mas  were  identified  among  hybridomas  from  two  of  the 
three  HA104  mice.  The  only  C12  antibodies  that  were 
identified  from  HA104  mice  were  a  pair of clonally-related 
hybridomas  derived  from  mouse  920  (hybridomas  920-18 
and  920-108)  that  expressed  the  VHC12.1/VK12  combi- 
nation  in  conjunction  with  either  IgG2a  or  Igm  constant 
regions.  By  contrast,  nearly  half of  the  hybridomas  from 
HA104  mice  expressed  the  VKC4/JK5  combination  that 
characterizes  C4  B  cells.  The  C4  hybridomas  were  all  IgM 
CDR1  r"  CDR2  --  --  C~3-- 
Vk4/5  28  38  am  50  60  70  8~  gO 
VkC]2  AASPGEKV'rTrc  SVSS .....  SISSSNLH  WY(~SETSPKI~I~  GTSNLA!  GVPVRFSGSGSGTSYSLTZSSMEAE[~ATYYC  (~SSYP 
92Z-177  ................  ￿9 ￿9 ￿9  .......  , .............................................................  tl 
92Z-64  ....  .  ....  -  .......  ,  .............................................................  y. 
922-72  ....  .  ....  -  .....................................................................  W- 
922-122  ........  .  ....  - .......  ,  ............................................................... 
922-143  ....  .  ....  - .......  , ............................................................... 
928-18  ..........  .  ....  - .......  ~ ............................................................... 
9Ze-1~8  ..........  .  ....  - .......  ,  .............................................................. 
922-181  ....  ~ ....  -.  ￿9 ￿9 .-  .......  ,  ............................................................  W- 
922-163  ..............  L .....  -  ............................. 
1M3-84 
1343-526 
921-178 
VkC4 
928-241 
928-57 
928-177 
1343-18 
1343-512 
1343-138 
922-52 
922-1418 
921-183 
921-124 
921-143 
9Z1-145 
921-18Z 
921-211 
921-192 
921-25 
928-293 
Vk19 
922-22 
922-23 
922  -42 
Vk9 
921-1415 
928-289 
Vk12/13 
922-1618 
.......  -N--  RA--.  ......  -V-YM- 
..........  A--.  ......  -V -YM- 
N--  -A--.  ......  -V-YM- 
.....  P~  .......  A----D- 
-F---PG----L---  S----A- 
......  G----R---  D--K--- 
.......................................  F- 
P--A--T-T  ...........  RV ...............  N-P- 
G--A  ................  R .............  R--Y-P) 
---A  .................................  N-P- 
KVTNS(  KSSQSLLNSGN~KNYLT  WYQQKPGQPPKLLIY  WASTRES  GVP~GSGSGT~TISSVQAEDLAVYY(  QflDYSYPtl 
FGAGIX  3k5 
--G---  3kZ 
--G---  3kl 
--S---  3k4 
--S---  3k4 
......  LE  3k5 
......  LE  3k5 
--G---  3kl 
--S---  Jk4 
--G--  JkZ 
--G---L  3k2 
--G---  3kl 
FCAGTKLE  3k5 
............................................................................................  JkS 
........................................................................................  3k5 
.................................................  JkS 
.......................................................  X  ....................................  3k5 
............................................................................................  Jk5 
......................................................  X .....................................  3k5 
.......................................................................................  .1kS 
..............................................................................  3kS 
.......................................................................................  3k5 
.......................................................................................  3k5 
.......................................................................................  3k5 
...........................................................................................  3k5 
............................................................................................  3kS 
..............................................................................  JkS 
..................................................................................  Y-  --G---  JkZ 
.................................  G .........................................  H ..........  Jk5 
..............  S ..............  S----V-  F .....  S  ......  I  .....................  D-F-  -QH--T-Y-  --G---  ]kZ 
KASQ  ......  DVGTAVI  WY(~KPGQSPKLLIY  ffASTRHT  ~VPDRFTGSGSGTDFTLTISNVQSEOLADYFC  ~YSSYPL1  FGSG  3k4 
....  ,  .....  -  ......  ,  ..............................................................  ~  ....  T  3k4 
....  , .....  -  ......  .  ..............................  ~  ....  3k4 
GKVTIT  ~ASQ ......  DINKYI~  WYQHNPGKGPRLLIH  YTSTLQF  GIPSRFSGSGSGRDYSFSISNLEPEDIATYYC  LQYDflLLF~  FGGGT  3kZ 
.......  . ....  .  .....  -  ..........  K ................  S  .......................................  .1  .....  3kl 
WTITC  ~ASG ......  NIHHYLA  WYqqKQGKSPQLLVY  ~0  GVPSRFSGSGSGTQYSLKINSLQPEDFGSYYC  ~HFWSTPW1  FGGGTKLE  3kZ 
Figure 7.  Deduced amino acid sequences 
of VL regions of PR8 HA-specific hybrido- 
mas from non-Tg and HA104 mice. Hybri- 
doma designations are as described in Fig. 5. 
Sequences  have  been  assembled according 
to VK gene group (which is indicated), and 
they are displayed in reference to a member 
of  each  group;  hybridomas  that  use  the 
VKC12 and VKC4 genes are shown relative 
to these previously described sequences (24, 
26).  Identity  with  the  representative  se- 
quence  is  indicated  by  dashes,  differences 
are indicated by the single-letter amino acid 
code,  and ambiguities are  indicated  by X. 
The  sequences are  numbered according to 
Kabat et al.  (49),  and the locations of CDR. 
are  indicated.  Gaps  that  have  been  intro- 
duced to  maintain alignment are  indicated 
by dots. The JK gene segment that is utilized 
is also  indicated.  The nucleotide sequences 
of these V regions are available from EMBL/ 
Genbank/DDJB  under  accession  numbers 
U37878-U37912. 
21  Caton et al. Table 2.  Differential  Expression ofC12 and C4 Clonotypes in HA-specific Hybridomas  fiom Non-Tg and HAl04 Mice 
Non-Tg  HA104 
H  H 
Hybridoma  isotype  VH/JH  VK/JK  Hybridoma  isotype  VH/JH  VK/JK 
922-64  G2a  VHC12.1/JH1  VKC12/JK2  921-124  M 
922-72  G2a  VHC12.1/JH3  VKC12/JK1  921-103  M 
922-122"  G2a  VHC12.1/JH1  VKC12/JK4  921-143  M 
922-143"  G2a  VHC12.1/JH1  VKC12/JK4  921-145  M 
922-177  G2a  VHC12.1/JH2  VKC12/JK5  921-182  M 
921-211  M 
922-101  G2a  VHQ52/JH4  VKCI2/JK1  921-102  M 
922-163  G2a  VHJ558/JH1  VKC12/JK4 
921-25  M 
992-52  M  VHQ52/JH4  VKC4/JK5  921-148  M 
922-1418  M  VH7183/JH2  VKC4/JK5  921-151  M 
921-178  G2a 
922-22*  G3  VH7183/JH4  VK19/JK4  921-1415  M 
922-23*  G2b  VH7183/JH4  VK19/JK4 
922-42*  G2a  VH7183/JH4  VK19/JK4 
922-207  M  ND  (not C4, C12) 
922-1311  G2b  ND  (not C4, C12) 
922-1610  G2b  ND  VK12,13/JK1 
922-1819  G2a  VHJ558/JH4  (not C4, C12) 
VHQ52/JH4  VKC4/JK5 
VHQ52/JH4  VKC4/JK5 
VHS107/JH2  VKC4/JK5 
VH7183/JH3  VKC4/JK5 
VH36-60/JH3  VKC4/JK5 
VHJ606/JH4  VKC4/JK5 
VHQ52/JH4  VKC4/JK2 
VHJ558/JH3  VK8/JK5 
ND  (not C4, C12) 
ND  (not C4, C12) 
VHJ558/JH1b  VK4,5/JK1 
VHJ558/JH4  VK9/JK2 
920-18"  G2a  VHC12.1/JH3  VKC12/JK5 
920-108"  M  VHC12.1/JH3  VKC12/JK5 
920-14  M  VHJ558/JH1  VKC4/JK5 
920-57  M  VH7183/JH4  VKC4/JK5 
920-177  M  VHQ52/JH4  VKC4/JK5 
920-241  M  ND  VKC4/JK5 
920-257  G3  ND  (not C4, C12) 
920-289  M  ND  VK9/JK1 
920-293  G2a  VHJ558/JH1  VK8/JK2 
1343-18"  M  VHS107/JH3  VKC4/JK5 
1343-512"  M  VHS107/JH3  VKC4/JK5 
1343-138  M  VHJ558/JH2  VKC4/JK5 
1343-84  M  VHJ558/JH1  VK4,5/JK2 
1343-88  M  VHJ558/JHlb  (not C4, C12) 
1343-1215  M  VHQ52/JH4  ND 
1343-526  G2b  VHJ558/JH1b  VK4,5/JK2 
The VH and VK gene families, as well as the JH and JK gene segments used by PP,.8 HA-specific hybridomas from non-Tg mouse 922, and by 
HA104 mice 921,920, and 1343 are shown. Gene segment combinations that are characteristic of the C12 and C4 clonotypes are shown in bold. 
The hybridoma H chain isotype is also indicated. For each mouse, hybridomas that use the same or related V gene sequences have been grouped to- 
gether. These include sets of clonally related hybridomas, which are indicated by asterisks (*). Hybridomas that yielded mixed L chain sequences 
when analyzed using a degenerate VK-specific primer, but that did not amplify in the PCP, with VKC4- or VKC12-specific primers, are indicated as 
(not C4, C12). ND, not determined. 
isotype, and they used a similar variety of VH regions as have 
previously been identified among C4 B  cells from BALB/c 
mice.  Three  of the  remaining  hybridomas  from  HA104 
mice (including two of the five IgG-secreting B  cell hybri- 
domas that were isolated) used a particular VHJ558/JH 1 gene 
segment combination that was derived from the C57/BL6 
background. Since we have not extensively characterized how 
this gene segment participates in the anti-HA responses of 
non-Tg mice, the significance of this finding is not clear. It 
22 
is, however,  apparent that hybridomas expressing the C12 
clonotype were substantially less frequent among day 5 hy- 
bridomas from HA104 mice. C4 hybridomas, on the other 
hand, were readily isolated from HA104 mice. 
Discussion 
To analyze how reactivity with a defined self  antigen shapes 
the primary B  cell repertoire, we generated transgenic mice 
that  express the influenza virus PR8  HA as a  membrane- 
Activation and Negative Selection of Hernagglutinin-specific B cells bound neo-self antigen  (HA104 mice). HA104 mice were 
compared with non-Tg mice for the specificity of their HA- 
specific B  cell responses after primary virus immunization. 
Overall, our analyses indicate that functionally distinct sub- 
sets ofPR8 HA~pecific B cells can be activated, or are neg- 
atively selected from the primary B cell repertoire in HA104 
mice. In particular, a subset of HA-specific B cells that give 
rise to IgM ASC was induced to similar levels in virus-immu- 
nized non-Tg and HA104 mice. By contrast, a subset oflgG- 
secreting ASC that arise rapidly and disappear abruptly after 
primary virus immunization in non-Tg mice was substantially 
reduced in HA104 mice. 
Several previous reports have described the induction of 
autoantibody responses to transgene-encoded neo-selfanti- 
gens. For example, autoantibodies could be induced in trans- 
genic mice expressing low levels of soluble lysozyme, mem 
brane-bound vesicular stomatitis  virus glycoprotein in a vari- 
ety of tissues, and the influenza virus HA expressed on pan- 
creatic ]3 islet cells  (16,  41,  56,  57).  In each case,  autoanti- 
body responses were induced when mice were immunized 
with  the  neo-self antigen  linked  to  a  carrier protein  as  a 
source  of cognate T  cell help.  Since these transgenic  mice 
mounted reduced T  cell responses to the neo-self antigen 
and  failed  to  generate  autoantibody  responses  without  a 
source of cognate help, these findings indicated that the in- 
duction  of T  cell  tolerance  can play an important role in 
controlling autoantibody responses  to self-antigens  (16,  41, 
42).  We  have recently demonstrated  that  transgenic  mice 
expressing the HA in the thymus mediate negative selection 
of CD4 + T  cells directed to the major I-Ea-restricted T  cell 
determinant from the HA (30).  To rule out the possibility 
that changes in the B  cell responses in HA104 mice might 
be  caused by T  cell tolerance  to  the  HA,  we  challenged 
HA104  mice with  intact influenza virus so that  CD4 +  T 
cells directed to other viral proteins could provide a source 
ofintermolecular cognate help to HA-specific B cells (16, 41- 
43). Under these conditions, we observed a clear reduction in 
the  frequency of PR8  HA~specific,  IgG-secreting B  cells 
that were induced  5  d  after virus immunization.  One ex- 
planation  for  this  could  be  that  despite  the  provision  of 
help to HA-specific B  cells by T  cells directed to other vi- 
rus  proteins,  the  induction  of IgG B  cells  in  the primary 
HA-specific response requires direct help from HA-specific 
T  cells.  In adoptive transfer experiments,  however,  T  cell 
clones  directed  to  the  virus  matrix  protein  and  the  HA 
were previously found to be equally efficient in promoting 
class-switching of the PR8 HA-specific antibody responses 
of nude mice (43).  A lack of appropriate help from CD4 + 
T  cells in HA104 mice appears unlikely to explain the fail- 
ure  to induce  the subset of PR8  HA-specific IgG B  cells 
that arises 5 d after immunization in non-Tg mice. 
The specificity of  B cell responses to the mutant virus T3 
provided direct evidence that PR8 HA-specific IgG B cells 
are negatively selected in HA104 mice. Several previous stud- 
ies have demonstrated that xeno- or alloantisera  raised against 
variants of self  proteins such as MHC molecules or hemoglo- 
bin are focused toward epitopes that contain amino acid dif- 
ferences from the self protein (46-48).  This skewing of the 
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antibody response toward foreign determinants reflects the 
regulation of autoreactive B  cells  that can cross-react with 
shared epitopes on the self  protein, and provided some of the 
earliest evidence for B  cell tolerance to self proteins  (58). 
The  frequency  of T3  virus-induced  hybridomas  that  re- 
acted  with  the  T3  HA but  did  not  cross-react with  the 
PR8 HA doubled from 15% of the hybridomas from non- 
Tg mice to 33% of the hybridomas from HA104 mice. The 
difference in the relative frequency of T3 HA-specific hy- 
bridomas was even greater among IgG hybridomas, increas- 
ing from 9% of the hybridomas from non-Tg mice, to 50% 
of the hybridomas isolated from HA104  mice. Moreover, 
the  increase  in  the  relative  frequency of IgG hybridomas 
that could only react with the mutant T3 epitope was caused 
by a decrease in the absolute frequency of PR8 HA~pecific 
IgG hybridomas in HA104 versus non-Tg mice. A  similar 
skewing in reactivity toward the T3 epitope, and away from 
reactivity with the PR8 HA, was apparent among the IgG 
ASC present in splenocytes 5 d after immunization with T3 
virus. By contrast, no skewing in reactivity toward the T3 
epitope  was  observed among the  IgM B  cells  in  HA104 
mice. Indeed, no substantial differences were evident in the 
kinetics or frequencies of HA-specific IgM ASC that were 
induced in HA104 and non-Tg mice. Together, these data 
strongly suggest that the PR8 HA-specific IgG-secreting B 
cells that arise 5 d after immunization of non-Tg mice are 
negatively selected from the  primary B  cell  repertoire  of 
HA104 mice because of their specificity for the PR8 HA. 
The conclusion that a subset of HA-specific B cells is neg- 
atively selected in HA104 mice is further supported by the 
relative representation ofhybridomas expressing V region se- 
quences that characterize the C12 and C4 clonotypes. The 
C12 and C4 clonotypes have previously been defined from 
analyses of the  anti-PR.8  HA B  cell responses of BALB/c 
mice. C12 antibodies recognize epitopes in the antigenic site 
Cb,  and they dominate  the  early primary response to  the 
PP.8  HA in BALB/c mice; roughly a quarter of the PP.8 
HA-specific B cell hybridomas generated 5 d after immuni- 
zation of  BALB/c mice express C12 antibodies (26). C4 anti- 
bodies recognize epitopes in the antigenic site Sb, and they 
are also characteristic  of day 5 hybridomas from BALB/c mice 
(24).  Consistent with these previous studies,  C12 antibodies 
comprised roughly a  quarter of the hybridomas that were 
generated here from a non-Tg mouse. C4 antibodies were 
also  represented  in  this  panel,  at  a  lower frequency than 
C12.  In hybridomas from HA104 mice, however, the rep- 
resentation ofC12 and C4 antibodies was reversed: no C12 
hybridomas were identified  among hybridomas from two 
of the three HA104 mice. The only C12 antibodies isolated 
from HA104 mice were a pair of clonally-related C12 hy- 
bridomas  (expressing either IgM or IgG constant regions) 
from mouse 920. By contrast, roughly half of the hybrido- 
mas from each of the three HA104 mice expressed C4 anti- 
bodies.  Moreover,  the  C12  antibodies from non-Tg mice 
were all IgG isotype, and the C4 antibodies from either non- 
Tg or HA104 mice were all IgM isotype. Accordingly, the 
differential expression of the C12 and C4 clonotypes corre- 
lates well with the other data here indicating that the PR8 HA~specific  IgG-secreting B  cells  that  arise  5  d  after im- 
munization  in  non-Tg mice are reduced  in HA104  mice. 
Indeed,  C12  B  cells  appear  to  be  substantially  eliminated 
from the primary B  cell repertoire of HA104 mice. 
The finding that C12 and C4 B cells differ in their suscep- 
tibility to negative selection from the primary repertoire  of 
HA104 mice is noteworthy in light of the different pheno- 
typic potentials that B  cells expressing these clonotypes dis- 
play in virus-immunized  BALB/c  mice.  Although  C12  B 
cells dominate day 5 hybridoma panels, they are absent from 
hybridoma panels generated 10 d after immunization; more- 
over, C12 antibodies make little or no contribution  to sec- 
ondary responses to the HA (29).  In the case ofC12 B  ceils, 
therefore, virus immunization appears to induce terminal dif- 
ferentiation  primarily  into  IgG ASC,  and  it  results  in  the 
elimination of C12 B  cells from the HA-specific repertoire 
of BALB/c mice. Clonal elimination as a consequence  of a 
strong immune response has been observed in mature T  ceils 
responding  to  Mls  (59)  and  to  certain  viral  antigens  (60), 
and it is consistent with early findings of hyporesponsiveness 
among animals previously injected with large antigen doses 
(61, 62). By contrast,  C4 B  cells participate in both primary 
and secondary responses to the HA; C4 hybridomas can be 
isolated from hybridoma panels generated 10 d after primary 
virus immunization  (63), and somatically mutated  C4 anti- 
bodies can be obtained  from secondary anti-HA responses 
of BALB/c mice (24). Since C12 cells but not C4 B  cells are 
eliminated from the primary repertoire of HAl04 mice, the 
findings of this report provide evidence that similar processes 
may induce a subset of HA-specific B cells to undergo termi- 
nal differentiation to produce IgG ASC during the primary 
response to the  HA in BALB/c  mice,  and also signal their 
negative  selection  during  primary  repertoire  formation  in 
HA104 mice. 
Why do C12 and C4 B ceils differ in their susceptibility to 
negative selection in HA104 mice, and display distinct phe- 
notypic  potentials  in non-Tg mice?  It is possible that C12 
B  cells are generally more sensitive to activation than C4 B 
cells,  perhaps because they have higher affinities for the HA. 
By this model, the higher sensitivity ofC12 B cells could pro- 
mote their terminal differentiation into IgG-secreting ASC 
in virus immunized non-Tg mice. Likewise, a greater sen- 
sitivity to activation could make C12 B cells more suscepti- 
ble to negative selection in HA104 mice. C4 B cells, on the 
other hand,  might persist in HA104 mice because their re- 
activity with the HA fails below a threshold that signals neg- 
ative selection ofC12 B cells.  C12 B cells could be negatively 
selected in HA104  mice by reacting with  the neo-self HA 
as a membrane-bound self antigen during their development 
in the bone marrow (13, 64), or because they react with the 
HA in the periphery in the absence ofT  cell help (65, 66). 
Our data also do not exclude the possibility that C12 B  cells 
could be particularly sensitive to T  ceil-mediated and/or id- 
iotype-specific suppression in HA104 mice (and in non-Tg 
mice undergoing primary responses to the HA) (67), although 
it is unclear how such suppression might be mediated. 
Alternatively, the C4 and C12 clonotypes might represent 
antigen-specific B cells that differentiate along different path- 
ways in response to stimulation by the HA. The notion that 
B  cells can undergo different developmental programs in re- 
sponse  to  antigenic  stimulation  is  consistent  with  current 
models that ASC and memory B cells develop as phenotypi- 
catly distinct populations in discrete anatomical locations (pefi- 
arteriolar  lymphoid  sheaths  and  germinal  centers,  respec- 
tively) (3, 6, 9). Moreover, ASC and germinal center B  cells 
appear to have  quite  different potentials  for postactivation 
events,  such  as  antibody  secretion  and  somatic  mutation 
(4-10).  The  factors  that  drive  B  cell  differentiation  along 
these different pathways are not yet understood.  Germinal 
center  B  cells and  primary response ASC  may derive  from 
common precursor pools and undergo  differentiation along 
different  pathways  in  response  to  receptor-mediated  (or 
perhaps  stochastic)  events  (8),  or  may derive  from  B  cell 
populations  that  are precommitted  to  develop  along these 
different pathways (4). The results here suggest that recep- 
tor mediated  and/or  developmentally  programmed  events 
may  likewise  induce  HA-specific  B  cells  to  develop  into 
functionally  distinct  subsets  of HA-specific  ASC,  affecting 
their  activation  potential  in  non-Tg  mice  and  influencing 
their  negative  selection  from  the  primary  repertoire  of 
HA104 mice. In this regard, it will also be interesting to ex- 
amine the  development  of C4  B  cells at later stages of the 
primary response and after secondary virus immunization  of 
HA104 mice since this may provide insights into the regula- 
tion of self-reactive B cells in the germinal center pathway. 
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